Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmar C Lehmann

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Der Nervenarzt|July 19, 2022
[Neuromuscular manifestations in long-COVID syndrome]Helmar C Lehmann
CNS & Neurological Disorders Drug Targets|September 30, 2010
Schwann cells as a therapeutic target for peripheral neuropathiesHelmar C Lehmann, Ahmet Höke
Brain Research|November 4, 2015
Use of engineered Schwann cells in peripheral neuropathy: Hopes and hazardsHelmar C Lehmann, Ahmet Höke
Experimental Neurology|December 19, 2020
Chemotherapy induced peripheral neurotoxicity: Six essential articles for effective future researchPaola Alberti, Helmar C Lehmann
Toxics|October 22, 2021
Pathomechanisms of Paclitaxel-Induced Peripheral NeuropathyInes Klein, Helmar C Lehmann
Journal of Neuroimmunology|November 9, 2010
Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathiesHelmar C Lehmann, Hans-Peter Hartung
Experimental Neurology|March 28, 2012
Progress in untying the Gordian nodes of Ranvier in Guillain-Barré SyndromeHelmar C Lehmann, Hans-Peter Hartung
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2010
Varicella-zoster virus: another trigger of Guillain-Barré syndrome?Helmar C Lehmann, Hans-Peter Hartung
Brain : a Journal of Neurology|May 3, 2008
Complementing the therapeutic armamentarium for Miller Fisher Syndrome and related immune neuropathiesHelmar C Lehmann, Hans-Peter Hartung
Neurology|September 25, 2009
Predicting treatment responses to IV immunoglobulins: can we already ask the genes?Helmar C Lehmann, Bernd C Kieseier
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Der Nervenarzt|July 19, 2022
[Neuromuscular manifestations in long-COVID syndrome]Helmar C Lehmann
CNS & Neurological Disorders Drug Targets|September 30, 2010
Schwann cells as a therapeutic target for peripheral neuropathiesHelmar C Lehmann, Ahmet Höke
Brain Research|November 4, 2015
Use of engineered Schwann cells in peripheral neuropathy: Hopes and hazardsHelmar C Lehmann, Ahmet Höke
Experimental Neurology|December 19, 2020
Chemotherapy induced peripheral neurotoxicity: Six essential articles for effective future researchPaola Alberti, Helmar C Lehmann
Toxics|October 22, 2021
Pathomechanisms of Paclitaxel-Induced Peripheral NeuropathyInes Klein, Helmar C Lehmann
Journal of Neuroimmunology|November 9, 2010
Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathiesHelmar C Lehmann, Hans-Peter Hartung
Experimental Neurology|March 28, 2012
Progress in untying the Gordian nodes of Ranvier in Guillain-Barré SyndromeHelmar C Lehmann, Hans-Peter Hartung
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2010
Varicella-zoster virus: another trigger of Guillain-Barré syndrome?Helmar C Lehmann, Hans-Peter Hartung
Brain : a Journal of Neurology|May 3, 2008
Complementing the therapeutic armamentarium for Miller Fisher Syndrome and related immune neuropathiesHelmar C Lehmann, Hans-Peter Hartung
Neurology|September 25, 2009
Predicting treatment responses to IV immunoglobulins: can we already ask the genes?Helmar C Lehmann, Bernd C Kieseier
Pageof 15